Publications
209
Citations
8,019
Est. group size
~3
Recurring co-author estimate
Active years
34
Publishing since 1993
This record appears to combine work from multiple researchers named Yan Wang, spanning cancer biology (especially breast, esophageal, and prostate cancer), clinical oncology trials, molecular mechanisms in model organisms like fruit flies, and other biomedical topics such as brain imaging, critical care recovery, and diabetes-related vascular disease. Because the publication list covers such varied subfields with different methods and study types, it likely represents a shared name rather than one coherent research program. Prospective students should look for more specific departmental or institutional context to identify which individual and research focus this profile actually represents.
Publication output has fluctuated over the last decade without a clear steady increase or decrease, with peak years (2020, 2023, 2025) interspersed with lower-output years, averaging about 10 papers per year over the last 5 years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Correction: Primary diffuse large B-cell lymphoma of the lip: a case report and literature review
Frontiers in Oncology · 2026
- Primary diffuse large b-cell lymphoma of the lip: a case report and literature review
Frontiers in Oncology · 2026
- ILP4 and InR regulate paclitaxel-induced hypersensitivity differently in <i>Drosophila</i> larvae
Molecular Biology of the Cell · 2025
- The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression
Cancer Cell · 2025
- ILP4 and InR regulate Paclitaxel-induced hypersensitivity differently in <i>Drosophila</i> larvae
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Systematic Review and Meta-Analysis of Traditional Chinese Medicine Bath in the Treatment of Neonatal Jaundice
Journal of Clinical Review & Case Reports · 2025
- IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer
npj Precision Oncology · 2025
- Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
European Journal of Medicinal Chemistry · 2025
- Ixazomib or Lenalidomide combined with cyclophosphamide and dexamethasone in the treatment of elderly transplant-ineligible newly diagnosed multiple myeloma
Scientific Reports · 2025
- SQLE amplification accelerates esophageal squamous cell carcinoma tumorigenesis and metastasis through oncometabolite 2,3-oxidosqualene repressing Hippo pathway
Cancer Letters · 2025
- Microstructure changes of the brain preceded glymphatic function changes in young obesity with and without food addiction
Meta-Radiology · 2025
- Evaluating the Effect of Respiratory and Hemodynamic Support During Critical Illness on Cognitive Function After Recovery
American Journal of Respiratory and Critical Care Medicine · 2025
- Abstract P4-08-19: Phase I Safety and Efficacy Study of Autophagy Inhibition to Augment the Antiproliferative and Biological Effects of Low Dose Palbociclib plus Letrozole in Estrogen Receptor-Positive, HER2-negative Metastatic Breast Cancer (MBC)
Clinical Cancer Research · 2025
- MA10.05 Phase I/II Study of Nivolumab and Ipilimumab With Concurrent Stereotactic Radiosurgery for Intracranial Metastases From NSCLC
Journal of Thoracic Oncology · 2025
- Sqle Amplification Accelerates Esophageal Squamous Cell Carcinoma Tumorigenesis and Metastasis Through Oncometabolite 2,3-Oxidosqualene Repressing Hippo Pathway
SSRN Electronic Journal · 2024
- Cancer Research×12
- Research Square×6
- bioRxiv (Cold Spring Harbor Laboratory)×5
- Cancer Cell×4
- Clinical Cancer Research×3
- Christian A. Showalter
Medicine · The Ohio State University
- Manoel Figueiredo Neto
Medicine · Purdue University West Lafayette
- Gunjan Agarwal
Medicine · The Ohio State University
- Charles S. Umbaugh
Medicine · Purdue University West Lafayette
- Aparna Shinde
Medicine · Purdue University West Lafayette
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile